Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Novavax Grows Presence at World Vaccine Congress and 32nd European Congress of Clinical Microbiology & Infectious Diseases 2022-04-18 22:13
Illumina Singapore Jumps the Ranks to Earn Two Significant Spots in Singapore's Best Employers Award 2022-04-18 12:00
DEBIOPHARM ANNOUNCES ONCOLOGY RESEARCH ADVANCEMENTS AT AACR 2022 FOR NOVEL CANCER COMPOUNDS AND DRUG DELIVERY TECHNOLOGIES 2022-04-14 21:20
CDD Vault Integrates with SnapGene Server for Web-Based Sharing of Plasmid Information 2022-04-14 20:45
International Team Led by BGI Completes First Whole-Body Cell Atlas of a Non-Human Primate 2022-04-14 16:43
International Team Led by BGI Completes First Whole-Body Cell Atlas of a Non-Human Primate 2022-04-14 16:30
Insilico Medicine Announces Advancement of Its Preclinical Candidate for USP1 Synthetic Lethality Target to IND-enabling Studies for Various Oncological Disorders 2022-04-13 23:00
European Wellness Signs MOU in Dubai Expo 2020 to Strengthen Medical Tourism into Malaysia and Develop Advanced Biological Regenerative Medicine in UAE 2022-04-13 21:38
JUNIPER BIOLOGICS ACQUIRES CELL-MEDIATED GENE THERAPY TG-C LD FOR TREATMENT OF KNEE OSTEOARTHRITIS 2022-04-13 07:57
Gastrointestinal Biotech Company Renexxion Ireland Announces $100M Investment Commitment 2022-04-12 20:00
New Clinical Advisory Board to support PromarkerD global rollout 2022-04-12 16:04
Abbott Senior Medical Director joins Nutromics as inaugural Chief Medical Officer 2022-04-12 09:28
The NDA of Henlius Novel Anti-PD-1 mAb Serplulimab for the First-Line Treatment of Small Cell Lung Cancer Accepted by NMPA 2022-04-11 22:07
Global pharma organizations back Turn Biotechnologies to advance its cell rejuvenation program 2022-04-11 19:00
Frost & Sullivan Hails Sphere Fluidics for Enabling Efficient, Faster, and More Cost-effective Single-cell Analysis with Its Microfluidic Platforms 2022-04-11 18:00
APRINOIA Therapeutics received FDA clearance to initiate APNmAb005 Phase 1 clinical trial 2022-04-11 18:00
Successful Passing Of The EU Qualified Person Audit Of The Group's Manufacturing Facility For ReCOV In Taizhou 2022-04-11 16:05
Antengene Announces Publication of Five Posters at the 2022 American Association for Cancer Research (AACR) Annual Meeting 2022-04-11 08:30
Telix Pharmaceuticals Announces Licence Agreement with Lilly for Olaratumab 2022-04-11 06:51
Gannex Announces First Patient Dosed in Phase II Clinical Trial of ASC42, an FXR Agonist, for Primary Biliary Cholangitis 2022-04-10 18:20
1 78 79 80 81 82 212